3D model is for representation purpose only.
.
.
![]() |
![]() |
![]() |
![]() |
![]() |
---|---|---|---|---|
XASXQSL | Doxorubicin |
Identification | |
---|---|
ConjuPepDB ID | cpd01298 |
Smiles | |
Molecular weight | 1395.6 |
Molecular formula | C65H89N9O25 |
Chemical name | Peptide information |
Sequence (one letter) | XASXQSL |
Length | 7 |
Peptide name | N/A |
External ID | |
---|---|
CAS number | 207395-85-5 |
Other information | |
---|---|
Application | Anticancer therapy, prostate |
Additional function | Improving stability |
Pharmacological class | anticancer |
Conjugate type | amide |
Linker | no |
Small molecule | Doxorubicin |
Small molecule CAS | 23214-92-8 |
Structure method | 1H NMR, RP-HPLC |
Calculated properties | |
---|---|
LogP | -3.28054 |
Rotatable bonds | 31 |
H bond donor | 17 |
H bond acceptor | 25 |
Polar surface area (PSA) | 545.14000 |
Citations | |||||
---|---|---|---|---|---|
ID | Title | Year | Authors | Journal | DOI |
Design of an IV Formulation of an Unstable Prodrug Candidate for Prostate Cancer Treatment: Solution Chemistry of N-(glutaryl-hyp-ala-ser-cyclohexylglycyl-gln-ser-leu)-doxorubicin | 2006 | Karki, Shyam; Treemaneekarn, Varaporn; Ostovic, Drazen; Nerurkar, Maneesh; Almarsson, Oern | Drug Development and Industrial Pharmacy |